1 Highlights of the 16th St Gallen International Breast Cancer Conference, Vienna, Austria, 20-23 March 2019: personalised treatments for patients with early breast cancer.

2 Bovine immune response to leptospira antigen in different novel adjuvants and vaccine delivery platforms.

3 The Effects of Glucosylation and O-Acetylation on the Conformation of Serogroup 2 O-Antigen Vaccine Targets.

4 Nanoparticle-based immunotherapy: state of the art and future perspectives.

5 Properties of Coronavirus and SARS-CoV-2.

6 Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses.

7 Letter in response to the article "Enhancing immunity in viral infections, with special emphasis on COVID-19: A review" (Jayawardena et al.).

8 Lactobacillus plantarum surface-displayed influenza antigens (NP-M2) with FliC flagellin stimulate generally protective immune responses against H9N2 influenza subtypes in chickens.

9 effect of zinc supplementation in children with severe pneumonia: a randomised controlled study

10 immune-enhancing effects of taishan pinus massoniana pollen polysaccharides on dna vaccine expressing bordetella avium ompa

11 alum activates the bovine nlrp3 inflammasome

12 vector design for improved dna vaccine efficacy, safety and production

13 controle químico de panicum repens e paspalum repens chemical control of panicum repens and paspalum repens

14 cumulative effect of risk factors on short-term surgical success of mitomycin augmented trabeculectomy.

15 aim2 co-immunization with vp1 is associated with increased memory cd8 t cells and mounts long lasting protection against coxsackievirus b3 challenge

16 tensão superficial dinâmica e ângulo de contato de soluções aquosas com surfatantes em superfícies artificiais e naturais dynamic surface tension and contact angle of water solutions with spray surfactants in artificial and natural surfaces

17 identification and biological activity of synthetic macrophage inducible c-type lectin ligands

18 toll-like receptor 3 signal in dendritic cells benefits cancer immunotherapy

19 immunological evaluation of recent muc1 glycopeptide cancer vaccines

20 sensing lipids with mincle: structure and function

21 vaccine adjuvants in fish vaccines make a difference: comparing three adjuvants (montanide isa763a oil, cpg/poly i:c combo and vhsv glycoprotein) alone or in combination formulated with an inactivated whole salmonid alphavirus antigen

22 enhancement of adjuvant functions of natural killer t cells using nanovector delivery systems: application in anticancer immune therapy

23 improved activity of imazethapyr onjimsonweed (datura stramonium l.)

24 carbonate apatite nanoparticles act as potent vaccine adjuvant delivery vehicles by enhancing cytokine production induced by encapsulated cytosine-phosphate-guanine oligodeoxynucleotides

25 Adjuvant therapy of pancreatic carcinoma: the experience of Policlinico Umberto I, Universit&agrave; &quot;Sapienza&quot; Rome

26 Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression.

27 Lactoferrin adsorption onto silver nanoparticle interface: Implications of corona on protein conformation, nanoparticle cytotoxicity and the formulation adjuvanticity

28 Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression.

29 Silver nanoparticle-adjuvanted vaccine protects against lethal influenza infection through inducing BALT and IgA-mediated mucosal immunity.

30 A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

31 Effect of Calcium and Vitamin D Supplements as an Adjuvant Therapy to Metformin on Menstrual Cycle Abnormalities, Hormonal Profile, and IGF-1 System in Polycystic Ovary Syndrome Patients: A Randomized, Placebo-Controlled Clinical Trial

32 A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

33 Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases

34 Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy

35 The Value of Intravoxel Incoherent Motion (IVIM) Magnetic Resonance Imaging in the Evaluation of the Osteosarcoma Response to Preoperative Neoadjuvant Chemotherapy in Teens

36 The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis

37 Correction to: Diastereoselective Colloidal Self-Assembly Affects the Immunological Response of the Molecular Adjuvant Sulfavant (ACS Omega (2019) 4:4 (7807?7814) DOI: 10.1021/acsomega.8b03304)

38 Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial

39 Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy.

40 [Risk factor analysis on anastomotic leakage after laparoscopic surgery in rectal cancer patient with neoadjuvant therapy and establishment of a nomogram prediction model].

41 A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol.

42 [Potential of Using Vitamin D as an Adjuvant Treatment of Malignant Melanoma].

43 Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity

44 Therapeutic benefits of Indole-3-Carbinol in adjuvant-induced arthritis and its protective effect against methotrexate induced-hepatic toxicity.

45 Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study.

46 5-Fluorouracil as an adjuvant therapy along with microneedling in vitiligo.

47 Serum microRNA-21 predicted treatment outcome and survival in HER2-positive breast cancer patients receiving neoadjuvant chemotherapy combined with trastuzumab.

48 A recombinant vaccine of Riemerella anatipestifer OmpA fused with duck IgY Fc and Schisandra chinensis polysaccharide adjuvant enhance protective immune response.

49 Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses

50 Opuntioside, opuntiol and its metallic nanoparticles attenuate adjuvant-induced arthritis: Novel suppressors of Toll-like receptors -2 and -4.

51 Cancer of the oesophagus and lymph nodes management in the neoadjuvant or definitive radiochemotherapy setting.

52 Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.

53 Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breast

54 Precision Adjuvant Therapy Based on Detailed Pathological Risk Factors for Resected Oral Cavity Squamous Cell Carcinoma: Long Term Outcome Comparison of CGMH and NCCN Guidelines.

55 Role of magnesium as analgesic sparing adjuvant to ropivacaine in thoracic paravertebral block for breast cancer surgery: A prospective, double-blinded randomised controlled study

56 Comparative evaluation of analgesic sparing efficacy between dexmedetomidine and clonidine used as adjuvant to ropivacaine in thoracic paravertebral block for patients undergoing breast cancer surgery: A prospective, randomized, double-blind study

57 Thoracic Paravertebral Block with Adjuvant Dexmedetomidine in Video-Assisted Thoracoscopic Surgery: A Randomized, Double-Blind Study.

58 Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system

59 Chemical Synthesis, Versatile Structures and Functions of Tailorable Adjuvants for Optimizing Oral Vaccination.

60 Direct-to-implant breast reconstruction after neoadjuvant chemotherapy: A safe option?

61 Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspective.

62 Adjuvant chemotherapy in colorectal cancer: mournful, hopeful perpetual motion machine heads to dim light at end of tunnel.

63 Adjuvant Chemotherapy in Colorectal Cancer: Mournful, Hopeful Perpetual Motion Machine Heads to Dim Light at End of Tunnel

64 Vitamin Supplementation as an Adjuvant Treatment for Alzheimer's Disease.

65 Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes.

66 Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer.

67 Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.

68 Reuterinos as adjuvant for peri-implant treatment: A pilot study.

69 Effectiveness of adjuvant occupational therapy in employees with Major Depression: a randomized controlled trial

70 Food additives as novel influenza vaccine adjuvants

71 Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic review.

72 COMPARISON BETWEEN FENTANYL 2 μG/mL VERSUS DEXMEDETOMIDINE 1.5 μG/mL AS ADJUVANTS WITH ISOBARIC BUPIVACAINE 0.0625% IN EPIDURAL LABOUR ANALGESIA

73 Temporal validation of metabolic nodal response of esophageal cancer to neoadjuvant chemotherapy as an independent predictor of unresectable disease, survival, and recurrence

74 Analgesic and antiinflammatory effects of dipyrone in rat adjuvant arthritis model.

75 Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.

76 Short-term outcomes of laparoscopically assisted surgery for rectal cancer following neoadjuvant chemoradiotherapy: a single-center experience.

77 Optimum Preparation Method for Self-Assembled PEGylation Nano-Adjuvant Based on and Its Immunological Effect on Macrophages.

78 Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines.

79 Time to Adjuvant Systemic Therapy Following Pancreatic Cancer Resection and Effect on Outcome.

80 Isothermal drying kinetics of sewage sludge using weathered coal fly ash as adjuvant for agronomic application.

81 Double Blinded Randomized Trial of Subcutaneous Trigeminal Nerve Stimulation as Adjuvant Treatment for Major Unipolar Depressive Disorder

82 The NeST (neoadjuvant systemic therapy in breast cancer) study - Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer.

83 The effects of Pythagorean Self-Awareness Intervention on breast cancer patients undergoing adjuvant therapy: A pilot randomized controlled trial.

84 Clonidine: An Adjuvant to Adrenaline in Local Anesthesia for Third Molar Surgery.

85 The Role of Adjuvant Therapy in Patients With Margin-Positive (R1) Esophagectomy: A National Analysis.

86 Does delayed initiation of adjuvant chemotherapy following the curative resection affect the survival outcome of gastric cancer patients: A systematic review and meta-analysis.

87 Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features

88 Change in 21-gene Recurrence Score result after exposure to neo-adjuvant endocrine therapy in patients with operable breast cancer.

89 Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.

90 Ipsilateral breast tumor recurrence in early stage breast cancer patients treated with breast conserving surgery and adjuvant radiation therapy: Concordance of biomarkers and tumor location from primary tumor to in-breast tumor recurrence.

91 Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial

92 Primary spinal glioblastoma treated with adjuvant radiation and temozolomide: Report of two cases.

93 Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England.

94 Post mastectomy adjuvant radiotherapy in breast cancer: a comparision of three hypofractionated protocols.

95 Timing of Adjuvant Radiotherapy in Glioblastoma Patients: A Single-Institution Experience With More Than 400 Patients.

96 Atypical Presentations and Management of Endocrine and Hepatic Immune-Related Adverse Events From Adjuvant Immune Checkpoint Inhibitor Therapy in Stage III Resected Melanoma.

97 Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: A systematic review and meta-analysis.

98 Fc functional antibody responses to adjuvanted versus unadjuvanted seasonal influenza vaccination in community-dwelling older adults.

99 EVALUATION OF OIL BASED AVIAN INFLUENZA VACCINE (H5NI) PREPARED WITH DIFFERENT CONCENTRATIONS OF ADJUVANT

100 Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy.

101 Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab

Keyword Connections

Journals

Research Groups

Bibliographies